CytoDyn (CYDY) Current Assets (2011 - 2026)
CytoDyn's (CYDY) quarterly Current Assets came in at $18.4 million in Q1 2026, down 12.13% YoY from $21.0 million in Q1 2025, and up 108.6% on a QoQ basis from $8.8 million in Q4 2025.
CytoDyn (CYDY) Current Assets (2011 - 2026) Analysis & Trends
CytoDyn (CYDY) has 16 years of Current Assets data on file, last reported at $18.4 million in Q1 2026.
- Quarterly Current Assets fell 12.13% year-over-year to $18.4 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $18.4 million (down 12.13% YoY) and the FY2025 annual result came in at $17.9 million, up 65.31% from the prior year.
- Current Assets improved to $18.4 million in Q1 2026, from $8.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $92.3 million in Q1 2022 to a low of $6.6 million in Q4 2022.
- A 5-year average of $18.7 million and a median of $12.0 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 93.57% — and 2024, when it soared 178.65%.
- Tracing CYDY's Current Assets over 5 years: stood at $6.6 million in 2022, then jumped by 34.94% to $8.8 million in 2023, then soared by 178.65% to $24.6 million in 2024, then sank by 64.12% to $8.8 million in 2025, then surged by 108.6% to $18.4 million in 2026.
- The last three Current Assets figures came in at $18.4 million (Q1 2026), $8.8 million (Q4 2025), and $13.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | 18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 18.44 Mn |
| Nov 30, 2025 | 8.84 Mn |
| Aug 31, 2025 | 13.35 Mn |
| May 31, 2025 | 17.88 Mn |
| Feb 28, 2025 | 20.98 Mn |
| Nov 30, 2024 | 24.63 Mn |
| Aug 31, 2024 | 27.74 Mn |
| May 31, 2024 | 10.82 Mn |
| Feb 29, 2024 | 9.91 Mn |
| Nov 30, 2023 | 8.84 Mn |
| Aug 31, 2023 | 11.97 Mn |
| May 31, 2023 | 10.81 Mn |
| Feb 28, 2023 | 14.11 Mn |
| Nov 30, 2022 | 6.55 Mn |
| Aug 31, 2022 | 9.86 Mn |
| May 31, 2022 | 10.52 Mn |
| Feb 28, 2022 | 92.35 Mn |
| Nov 30, 2021 | 101.81 Mn |
| Aug 31, 2021 | 102.79 Mn |
| May 31, 2021 | 36.10 Mn |